Checkpoint Therapeutics Inc (NASDAQ:CKPT)

Delayed Data
As of Dec 04
 +0.15 / +5.47%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Checkpoint Therapeutics Inc have a median target of 21.00, with a high estimate of 47.00 and a low estimate of 8.00. The median estimate represents a +642.05% increase from the last price of 2.83.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Checkpoint Therapeutics Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 14

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -231.90%
Growthannually 51.59%


Growthquarterly -13.98%
Growthannually -73.96%
Key to the earnings and sales forecast charts.